2020 (old version) | 2021 (new version) | Type of Change | Reason for Change | Burden Change |
N/A | Updated grammer and formatting of questions for easier understanding, with some streamlining of responses | Rev | To make it easier for repondent to complete the surveys. | Updated setence structure and formatting for easier understanding and to decrease work burden for respondants by 5 minutes |
N/A | Spelled out acroynms for easier understanding | Rev | To make it easier for repondent to complete the surveys. | To increase understanding for respondants-decrease work burden by 5 minutes |
N/A | Added questions about psychotrophic medications in children to address a GAO recommendation ANTIDEPRESSANTS 5.Does your state have a documented program in place to either manage or monitor the appropriate use of antidepressants drugs in children? a. Does your state either manage or monitor only children in foster care or all children b.Does your state have edits in place to monitor? c.Please briefly explain the specifics of your documented antidepressant monitoring program(s). If No,” does your state plan on implementing a stimulant monitoring program in the future? MOOD STABILIZERS 6.Does your state have a documented program in place to either manage or monitor the appropriate use of mood stabilizing drugs in children? a. Does your state either manage or monitor only children in foster care or all children b.Does your state have edits in place to monitor? c.Please briefly explain the specifics of your documented antidepressant monitoring program(s). If “No,” does your state plan on implementing a stimulant monitoring program in the future? ANTIANXIETY/SEDATIVES 7.Does your state have a documented program in place to either manage or monitor the appropriate use of antianxiety/sedative drugs in children? a. Does your state either manage or monitor only children in foster care or all children b.Does your state have edits in place to monitor? c.Please briefly explain the specifics of your documented antidepressant monitoring program(s). If “No,” does your state plan on implementing a stimulant monitoring program in the future? |
Add | GAO compliance | Increased work burden to collect information by 30 minutes |
Appendix drug tables | Deleted | Deleted | Appendices not needed, were not utilized | No net change |
When the pharmacist receives an early refill DUR alert message that requires the pharmacist’s review, does your state’s policy allow the pharmacist to override for situations such as | Streamlined responses and removed subquestions to decrease total number of questions for the states. | Rev | To make it easier for repondent to complete the surveys. | Decrease work burden for respondants by 10 minutes |
Individual questions about automated retrospective reviews | Subquestions were removed/streamlined into a single question regarding comprehensive retrospective reviews | Removed | To make it easier for repondent to complete the surveys. | Decrease work burden for respondants by 10 minutes |
total: | No net change |
File Type | application/vnd.openxmlformats-officedocument.spreadsheetml.sheet |
File Modified | 0000-00-00 |
File Created | 0000-00-00 |